IGC Pharma (IGC) Total Debt Growth (3y) (2014 - 2026)
IGC Pharma (IGC) Total Debt Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.08% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.52% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -22.87% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.30% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 4.76% |
| 10 | IGC Pharma | 30.17 Mn | 29.90 Mn | - | 126.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 126.71% |
| Dec 31, 2025 | 51.57% |
| Sep 30, 2025 | -2.40% |
| Jun 30, 2025 | -3.06% |
| Mar 31, 2025 | -3.04% |
| Dec 31, 2024 | -3.26% |
| Sep 30, 2024 | -3.24% |
| Jun 30, 2024 | -3.21% |
| Mar 31, 2024 | -38.18% |
| Dec 31, 2023 | -38.03% |
| Sep 30, 2023 | -37.89% |
| Jun 30, 2023 | -39.43% |
| Mar 31, 2023 | 41.28% |
| Dec 31, 2022 | 41.28% |
| Sep 30, 2022 | 41.61% |
| Jun 30, 2022 | 42.93% |
| Mar 31, 2022 | 43.26% |
| Dec 31, 2021 | 32.24% |
| Sep 30, 2021 | -12.84% |
| Jun 30, 2021 | -12.82% |